Cargando…
Diabetes‐mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction
Type 2 diabetes mellitus (T2DM) has been associated with an increased risk of cancer, including colon cancer (CC). However, we recently reported no influence of T2DM on CC prognosis, suggesting that any effect might be at the early stages of tumor development. We hypothesized that T2DM may create an...
Autores principales: | Del Puerto‐Nevado, Laura, Santiago‐Hernandez, Aranzazu, Solanes‐Casado, Sonia, Gonzalez, Nieves, Ricote, Marta, Corton, Marta, Prieto, Isabel, Mas, Sebastian, Sanz, Ana Belen, Aguilera, Oscar, Gomez‐Guerrero, Carmen, Ayuso, Carmen, Ortiz, Alberto, Rojo, Federico, Egido, Jesus, Garcia‐Foncillas, Jesus, Minguez, Pablo, Alvarez‐Llamas, Gloria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717745/ https://www.ncbi.nlm.nih.gov/pubmed/31199051 http://dx.doi.org/10.1002/1878-0261.12531 |
Ejemplares similares
-
Molecular evidence of field cancerization initiated by diabetes in colon cancer patients
por: Del Puerto‐Nevado, Laura, et al.
Publicado: (2019) -
Colon cancer modulation by a diabetic environment: A single institutional experience
por: Prieto, Isabel, et al.
Publicado: (2017) -
2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications
por: González, Nieves, et al.
Publicado: (2017) -
Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer
por: Cenigaonandia-Campillo, Aiora, et al.
Publicado: (2021) -
Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes
por: Manzanares-Martin, Barbara, et al.
Publicado: (2021)